Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

NCT05271630

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

NCT03589222

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hospital Germans Trials i Pujol Badalona, Spain

Hospital Clinic de Barcelona Barcelona, Spain

Hospital ICO de Girona Girona, Spain

Hospital ICO de L'hospitalet L'Hospitalet de Llobregat, Spain

View all 15 locations

View Trial Details

Active, Not Recruiting

Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A

NCT07439055

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +13 more
Locations: Chulalongkorn University Bangkok, Thailand

View Trial Details

Active, Not Recruiting

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

NCT04764942

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

NCT00378105

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States

UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States

The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States

View all 155 locations

View Trial Details

Active, Not Recruiting

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

NCT05587972

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +29 more
Locations: Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma

NCT05577000

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Active, Not Recruiting

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

NCT06126341

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hartford Healthcare Alliance Hartford, Connecticut, United States

Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

View Trial Details

Active, Not Recruiting

Immune Disorder HSCT Protocol

NCT01821781

Conditions: 22q11 Deletion Syndrome, Abnormalities, Multiple, Albinism, +66 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions